A study presented at EASD 2017 shows long-term A1C reductions through personalized insulin dose adjustments every eight weeks using Glytec’s therapy management software. WALTHAM, Mass.--(BUSINESS WIRE ...
WALTHAM, Mass.--(BUSINESS WIRE)--Glytec, the only provider of insulin management software across the continuum of care, today published the first proof-of-concept study that combines data from ...
ATLANTA, May 19, 2026 /PRNewswire/ -- Glytec, the leading provider of a glycemic management technology platform for hospitals and health systems, today announced that a joint research team with ...
Diabetes therapy management software company Glytec has just secured its fourth FDA clearance, adding a slew of capabilities to its Glucommander product, the core of its eGlycemic Management System.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results